How Do Combined Pharmacological And Psychotherapeutic Interventions Impact Treatment Outcomes For Patients With Treatment- Resistant Major Depressive Disorder? : A Systematic Review
Keywords:
Treatment-Resistant Depression, Major Depressive Disorder, Combined Therapy, Pharmacotherapy, Psychotherapy, Cognitive Behavioral Therapy, Mindfulness-Based Cognitive Therapy, Response Rates, Remission RatesAbstract
Introduction: Treatment-resistant major depressive disorder (TRD), characterized by an inadequate response to at least two antidepressant trials, presents a significant clinical challenge. Combined pharmacological and psychotherapeutic interventions have emerged as a promising strategy, potentially offering synergistic benefits over monotherapy by addressing both biological and psychological aspects of the disorder. This review synthesizes evidence on the efficacy, mechanisms, and clinical applicability of combined interventions for TRD. Methods: This systematic review followed PRISMA 2020 guidelines. Studies were included if they focused on adult patients with TRD, examined combined pharmacotherapy and psychotherapy, were randomized controlled trials (RCTs), systematic reviews, or meta-analyses, included quantitative depression measures, and had an intervention duration of at least 8 weeks. Searches were conducted in PubMed, Semantic Scholar, Sagepub, and Google Scholar. Results: Forty studies were included, comprising 20 RCTs and 19 systematic reviews/meta-analyses. Combined interventions generally demonstrated superior response and remission rates compared to monotherapy. For instance, one study found response rates of 30.3% for mindfulness-based cognitive therapy (MBCT) plus treatment as usual versus 15.3% for controls. Meta-analyses reported moderate effect sizes (Cohen’s d = 0.32–0.93) and risk ratios of 1.25–1.27 favoring combination therapy. Discussion: The findings underscore the superior efficacy of combined pharmacological and psychotherapeutic interventions for TRD. These approaches lead to significant improvements in response and remission rates, particularly in severe or chronic TRD. Conclusion: The evidence strongly supports combined pharmacological and psychotherapeutic interventions as the gold standard for TRD, offering enhanced efficacy, reduced relapse rates, and good tolerability. Future research should continue to optimize sequencing, explore novel adjuncts, and improve accessibility through digital platforms.
References
A. John Rush, and Shailesh Bobby Jain. “Clinical Implications of the STAR*D Trial.” Handbook of Experi- mental Pharmacology, 2019.
A. Mantani, Tadashi Kato, T. Furukawa, M. Horikoshi, H. Imai, Takahiro Hiroe, Bun Chino, et al. “Smart- phone Cognitive Behavioral Therapy as an Adjunct to Pharmacotherapy for Refractory Depression: Ran- domized Controlled Trial.” Journal of Medical Internet Research, 2017.
A. Schaub, Ulrich Goldmann, T. Mueser, S. Goerigk, M. Hautzinger, Elizabeth Roth, M. Charypar, Rolf R. Engel, and H. Möller. “Efficacy of Extended Clinical Management, Group CBT, and Group Plus Individual CBT for Major Depression: Results of a Two-Year Follow-up Study.” Journal of Affective Disorders, 2018.
Aoife Whiston, C. Bockting, and M. Semkovska. “Towards Personalising Treatment: A Systematic Review and Meta-Analysis of Face-to-Face Efficacy Moderators of Cognitive-Behavioral Therapy and Interper- sonal Psychotherapy for Major Depressive Disorder.” Psychological Medicine, 2019.
Brett D. M. Jones, L. Razza, C. Weissman, Jewel Karbi, Tya Vine, L. Mulsant, A. Brunoni, et al. “Magni- tude of the Placebo Response Across Treatment Modalities Used for Treatment-Resistant Depression in Adults.” JAMA Network Open, 2021.
Capilla Navarro, A. Yáñez, Aurora Garcia, Andrea Seguí, Francisco Gazquez, J. A. Marino, Olga Ibarra, et al. “Effectiveness of a Healthy Lifestyle Promotion Program as Adjunctive Teletherapy for Treatment- Resistant Major Depression During COVID 19 Pandemic.” Medicine, 2020.
Carly W Yasinski, Adele M. Hayes, C. B. Ready, Anna Abel, Nora Görg, and W. Kuyken. “Processes of Change in Cognitive Behavioral Therapy for Treatment-Resistant Depression: Psychological Flexibility, Rumination, Avoidance, and Emotional Processing.” Psychotherapy Research, 2019.
Dongdong Zhou, Xiaoxin Zhou, Qingxia Lin, Wo Wang, Zhen Lv, Xiao-rong Chen, Gang Nie, and L. Kuang. “Nonpharmacological Interventions for Relapse Prevention in Unipolar Depression: A Network Meta- Analysis.” Journal of Affective Disorders, 2021.
E. Driessen, J. Dekker, J. Peen, H. Van, G. Maina, G. Rosso, S. Rigardetto, et al. “The Efficacy of Adding Short-Term Psychodynamic Psychotherapy to Antidepressants in the Treatment of Depression: A Systematic Review and Meta-Analysis of Individual Participant Data.” Clinical Psychology Review, 2020.
Erica S. Weitz, A. Kleiboer, A. van Straten, S. Hollon, and P. Cuijpers. “Individual Patient Data Meta- Analysis of Combined Treatments Versus Psychotherapy (with or Without Pill Placebo), Pharmacother- apy or Pill Placebo for Adult Depression: A Protocol.” BMJ Open, 2017.
F. Gabriel, A. Stein, D. Melo, Géssica Caroline Henrique Fontes-Mota, Itamires Benício dos Santos, Camila da Silva Rodrigues, Andrea Dourado, et al. “Guidelines’ Recommendations for the Treatment-Resistant Depression: A Systematic Review of Their Quality.” PLoS ONE, 2023.
Gabriele Di Salvo, Camilla Perotti, V. Ricci, Giuseppe Maina, and G. Rosso. “Efficacy and Suitability of Adding Short-Term Psychodynamic Psychotherapy (STPP) to Pharmacotherapy in Patients with Depressive Disorders: A Systematic Review.” Trends in Psychiatry and Psychotherapy, 2024.
H. Riese, L. von Klipstein, R. Schoevers, D. C. van der Veen, and M. Servaas. “Personalized ESM Monitoring and Feedback to Support Psychological Treatment for Depression: A Pragmatic Randomized Controlled Trial (Therap-i).” BMC Psychiatry, 2021.
Holly B. Laws, Michael J. Constantino, A. Sayer, D. Klein, J. Kocsis, R. Manber, J. Markowitz, et al. “Convergence in Patient–Therapist Therapeutic Alliance Ratings and Its Relation to Outcome in Chronic Depression Treatment.” Psychotherapy Research, 2017.
I. Dalhuisen, F. Smit, J. Spijker, I. van Oostrom, E. van Exel, H. V. van Mierlo, Dieuwertje de Waardt, M. Arns, I. Tendolkar, and P. V. van Eijndhoven. “rTMS Combined with CBT as a Next Step in Antide- pressant Non-Responders: A Study Protocol for a Randomized Comparison with Current Antidepressant Treatment Approaches.” BMC Psychiatry, 2022.
J. Guidi, and G. Fava. “Sequential Combination of Pharmacotherapy and Psychotherapy in Major Depressive Disorder: A Systematic Review and Meta-Analysis.” JAMA Psychiatry, 2020.
K. Kamenov, C. Twomey, M. Cabello, A. Prina, and J. Ayuso-Mateos. “The Efficacy of Psychotherapy, Pharmacotherapy and Their Combination on Functioning and Quality of Life in Depression: A Meta- Analysis.” Psychological Medicine, 2016.
K. W. Lin, T. Wroolie, Thalia K. Robakis, and N. Rasgon. “Adjuvant Pioglitazone for Unremitted Depres- sion: Clinical Correlates of Treatment Response.” Psychiatry Research, 2015.
Kemal Akpınar, Nalan Kalkan Oğuzhanoğlu, and Tuğçe Toker Uğurlu. “Efficacy of Transcranial Magnetic Stimulation in Treatment-Resistant Depression.” Turkish Journal of Medical Sciences, 2022.
L. H. Souza, G. Salum, B. P. Mosqueiro, M. Caldieraro, T. A. Guerra, and M. Fleck. “Interpersonal Psychotherapy as Add-on for Treatment-Resistant Depression: A Pragmatic Randomized Controlled Trial.” Journal of Affective Disorders, 2016.
L. Koeser, F. Rost, Andrea Gabrio, T. Booker, D. Taylor, P. Fonagy, D. Goldberg, M. Knapp, and P. McCrone. “Cost-Effectiveness of Long-Term Psychoanalytic Psychotherapy for Treatment-Resistant De- pression: RCT Evidence from the Tavistock Adult Depression Study (TADS).” Journal of Affective Disorders, 2023.
Larissa Junkes, B. Gherman, J. Appolinario, and Antonio E Nardi. “Dialectical Behavior Therapy as an Intervention for Treatment Resistant Depression in Adults: A Protocol for Systematic Review and Meta- Analysis.” PLoS ONE, 2024.
Leigh A Andrews, Adele M. Hayes, Anna Abel, and W. Kuyken. “Sudden Gains and Patterns of Symptom Change in Cognitive-Behavioral Therapy for Treatment-Resistant Depression.” Journal of Consulting and Clinical Psychology, 2020.
M. Rodrigues, L. Quagliato, J. Appolinario, and Antonio E Nardi. “Online Mindfulness-Based Cognitive Therapy for Treatment-Resistant Depression: A Parallel-Arm Randomized Controlled Feasibility Trial.” Frontiers in Psychology, 2024.
Mayumi Fukumori, Toshiaki Kikuchi, Yi Zhou, Satoshi Hattori, and Takashi Kudo. “Network Meta-Analysis of the Effectiveness of Psychotherapies with or Without Medication for Treating Adult Depression.” Acta Neuropsychiatrica, 2024.
Mitsuhiro Sado, Akihiro Koreki, Akira Ninomiya, Chika Kurata, Dai Mitsuda, Yasunori Sato, Toshiaki Kikuchi, et al. “Cost‐effectiveness Analyses of Augmented Cognitive Behavioral Therapy for Pharma- cotherapy‐resistant Depression at Secondary Mental Health Care Settings.” Psychiatry and Clinical Neurosciences, 2021.
N. Watanabe, M. Horikoshi, M. Yamada, S. Shimodera, T. Akechi, Kazuhira Miki, M. Inagaki, et al. “Adding Smartphone-Based Cognitive-Behavior Therapy to Pharmacotherapy for Major Depression (FLATT Project): Study Protocol for a Randomized Controlled Trial.” Trials, 2015.
P. Cuijpers, H. Noma, E. Karyotaki, Christiaan H. Vinkers, Andrea Cipriani, and T. Furukawa. “A Net- work Meta‐analysis of the Effects of Psychotherapies, Pharmacotherapies and Their Combination in the Treatment of Adult Depression.” World Psychiatry, 2020.
P. Cuijpers, L. D. Wit, Erica S. Weitz, G. Andersson, and M. Huibers. “The Combination of Psychotherapy and Pharmacotherapy in the Treatment of Adult Depression: A Comprehensive Meta-Analysis,” 2015.
P. Fonagy, F. Rost, Jo-anne Carlyle, S. McPherson, Rachel Thomas, R. P. Pasco Fearon, D. Goldberg, and David Taylor. “Pragmatic Randomized Controlled Trial of Long‐term Psychoanalytic Psychotherapy for Treatment‐resistant Depression: The Tavistock Adult Depression Study (TADS).” World Psychiatry, 2015
R. Vida, E. Saghy, R. Bella, Sandor J. Kovacs, D. Erdősi, J. Józwiak-Hagymásy, A. Zemplényi, T. Tényi, P. Osvath, and V. Voros. “Efficacy of Repetitive Transcranial Magnetic Stimulation (rTMS) Adjunctive Therapy for Major Depressive Disorder (MDD) After Two Antidepressant Treatment Failures: Meta- Analysis of Randomized Sham-Controlled Trials.” BMC Psychiatry, 2023.
S. Eisendrath, Erin P Gillung, K. Delucchi, Z. Segal, J. Nelson, L. McInnes, D. Mathalon, and M. Feld- man. “A Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy for Treatment-Resistant Depression.” Psychotherapy and Psychosomatics, 2016.
S. V. van Bronswijk, Neha Moopen, L. Beijers, H. Ruhé, and F. Peeters. “Effectiveness of Psychotherapy for Treatment-Resistant Depression: A Meta-Analysis and Meta-Regression.” Psychological Medicine, 2018.
S. Zakhour, A. Nardi, M. Levitan, and João Carlos Borges Appolinario. “Cognitive-Behavioral Therapy for Treatment-Resistant Depression in Adults and Adolescents: A Systematic Review.” Trends in Psychiatry and Psychotherapy, 2020.
Shigetsugu Nakao, A. Nakagawa, Yoshiyo Oguchi, Dai Mitsuda, Noriko Kato, Y. Nakagawa, Noriko Tamura, et al. “Web-Based Cognitive Behavioral Therapy Blended With Face-to-Face Sessions for Major Depres- sion: Randomized Controlled Trial.” Journal of Medical Internet Research, 2018.
T. Barnhofer, B. Dunn, C. Strauss, F. Ruths, B. Barrett, M. Ryan, Asha Ladwa, et al. “A Randomised Controlled Trial to Investigate the Clinical Effectiveness and Cost Effectiveness of Mindfulness-Based Cognitive Therapy (MBCT) for Depressed Non-Responders to Increasing Access to Psychological Ther- apies (IAPT) High-Intensity Therapies: Study Protocol.” Trials, 2023.
T. Furukawa, E. Schramm, Erica S. Weitz, G. Salanti, O. Efthimiou, J. Michalak, N. Watanabe, et al. “Cognitive-Behavioural Analysis System of Psychotherapy (CBASP), a Drug, or Their Combination: Dif- ferential Therapeutics for Persistent Depressive Disorder: A Study Protocol of an Individual Participant Data Network Meta-Analysis.” BMJ Open, 2016.
V. Menon, Parthasarathy Ramamurthy, Sandesh Venu, and Chittaranjan Andrade. “Randomized Controlled Trials of Psilocybin-Assisted Therapy in the Treatment of Major Depressive Disorder: Systematic Review and Meta-Analysis.” Acta Psychiatrica Scandinavica, 2024.
Y. de Roten, G. Ambresin, F. Herrera, S. Fassassi, N. Fournier, M. Preisig, and J. Despland. “Efficacy of an Adjunctive Brief Psychodynamic Psychotherapy to Usual Inpatient Treatment of Depression: Results of a Randomized Controlled Trial.” Journal of Affective Disorders, 2017.
Yong Jia, Min Li, Zhaohua Cheng, Lianzhi Cui, Jinping Zhao, Yufei Liu, M. Leng, Feng Li, and Li Chen. “Morita Therapy for Depression in Adults: A Systematic Review and Meta-Analysis.” Psychiatry Re- search, 2018.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Julisman Itolo Dwijaya Daeli, Andy Soemara (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors publishing here keep copyright but grant the journal first publication rights, under a Creative Commons Attribution-NonCommercial 4.0 License. They can distribute their work non-exclusively elsewhere with an acknowledgment of its first publication in this journal. Posting the work online before and during submission for earlier and greater citation is encouraged, reflecting Open Access benefits.
